Meh. That word best describes the state of 2017 merger and acquisition activity in the clinical laboratory space, where firms continue to prefer alliance to absorption at a rate of over 3 to 1. But while the M&A year was relatively light in both volume and drama, it was not without its points of interest….
Industry Buzz: 2017-The Year in DX Mergers & Acquisitions
Meh. That word best describes the state of 2017 merger and acquisition activity in the clinical laboratory space, where firms continue to prefer alliance to absorption at a rate of over 3 to 1. But while the M&A year was relatively light in both volume and drama, it was not without its points of interest. […]